The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
HER2 Antibody-Global Market Insights and Sales Trends 2025
Synopsis
HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is recommended for all patients with HER2-positive breast cancer who are also receiving chemotherapy.
The global HER2 Antibody market size is expected to reach US$ 23040 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of HER2 Antibody in various end use industries. The expanding demands from the Hospital and Medical Center, are propelling HER2 Antibody market. Trastuzumab, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lapatinib segment is estimated at % CAGR for the next seven-year period.
Monoclonal antibodies targeting HER2 (human epidermal growth factor receptor 2) are used in the treatment of HER2-positive breast cancer. Market trends include the development of next-generation HER2-targeted therapies and combination therapies to enhance treatment efficacy.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HER2 Antibody, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global HER2 Antibody market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HER2 Antibody market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HER2 Antibody sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HER2 Antibody covered in this report include Genentech Inc, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited and Bio-Techne, etc.
The global HER2 Antibody market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Genentech Inc
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Global HER2 Antibody market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HER2 Antibody market, Segment by Type:
Trastuzumab
Lapatinib
Ado-trastuzumab Emtansine
Pertuzumab
Everolimus
Global HER2 Antibody market, by Application
Hospital
Medical Center
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of HER2 Antibody companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is recommended for all patients with HER2-positive breast cancer who are also receiving chemotherapy.
The global HER2 Antibody market size is expected to reach US$ 23040 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of HER2 Antibody in various end use industries. The expanding demands from the Hospital and Medical Center, are propelling HER2 Antibody market. Trastuzumab, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lapatinib segment is estimated at % CAGR for the next seven-year period.
Monoclonal antibodies targeting HER2 (human epidermal growth factor receptor 2) are used in the treatment of HER2-positive breast cancer. Market trends include the development of next-generation HER2-targeted therapies and combination therapies to enhance treatment efficacy.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HER2 Antibody, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global HER2 Antibody market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HER2 Antibody market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HER2 Antibody sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HER2 Antibody covered in this report include Genentech Inc, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited and Bio-Techne, etc.
The global HER2 Antibody market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Genentech Inc
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Global HER2 Antibody market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HER2 Antibody market, Segment by Type:
Trastuzumab
Lapatinib
Ado-trastuzumab Emtansine
Pertuzumab
Everolimus
Global HER2 Antibody market, by Application
Hospital
Medical Center
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of HER2 Antibody companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of HER2 Antibody
1.1 HER2 Antibody Market Overview
1.1.1 HER2 Antibody Product Scope
1.1.2 HER2 Antibody Market Status and Outlook
1.2 Global HER2 Antibody Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global HER2 Antibody Market Size by Region (2018-2029)
1.4 Global HER2 Antibody Historic Market Size by Region (2018-2023)
1.5 Global HER2 Antibody Market Size Forecast by Region (2024-2029)
1.6 Key Regions, HER2 Antibody Market Size (2018-2029)
1.6.1 North America HER2 Antibody Market Size (2018-2029)
1.6.2 Europe HER2 Antibody Market Size (2018-2029)
1.6.3 Asia-Pacific HER2 Antibody Market Size (2018-2029)
1.6.4 Latin America HER2 Antibody Market Size (2018-2029)
1.6.5 Middle East & Africa HER2 Antibody Market Size (2018-2029)
2 HER2 Antibody Market by Type
2.1 Introduction
2.1.1 Trastuzumab
2.1.2 Lapatinib
2.1.3 Ado-trastuzumab Emtansine
2.1.4 Pertuzumab
2.1.5 Everolimus
2.2 Global HER2 Antibody Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global HER2 Antibody Historic Market Size by Type (2018-2023)
2.2.2 Global HER2 Antibody Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America HER2 Antibody Revenue Breakdown by Type (2018-2029)
2.3.2 Europe HER2 Antibody Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific HER2 Antibody Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America HER2 Antibody Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa HER2 Antibody Revenue Breakdown by Type (2018-2029)
3 HER2 Antibody Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Medical Center
3.2 Global HER2 Antibody Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global HER2 Antibody Historic Market Size by Application (2018-2023)
3.2.2 Global HER2 Antibody Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America HER2 Antibody Revenue Breakdown by Application (2018-2029)
3.3.2 Europe HER2 Antibody Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific HER2 Antibody Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America HER2 Antibody Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa HER2 Antibody Revenue Breakdown by Application (2018-2029)
4 HER2 Antibody Competition Analysis by Players
4.1 Global HER2 Antibody Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HER2 Antibody as of 2022)
4.3 Date of Key Players Enter into HER2 Antibody Market
4.4 Global Top Players HER2 Antibody Headquarters and Area Served
4.5 Key Players HER2 Antibody Product Solution and Service
4.6 Competitive Status
4.6.1 HER2 Antibody Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Genentech Inc
5.1.1 Genentech Inc Profile
5.1.2 Genentech Inc Main Business
5.1.3 Genentech Inc HER2 Antibody Products, Services and Solutions
5.1.4 Genentech Inc HER2 Antibody Revenue (US$ Million) & (2018-2023)
5.1.5 Genentech Inc Recent Developments
5.2 Novartis AG
5.2.1 Novartis AG Profile
5.2.2 Novartis AG Main Business
5.2.3 Novartis AG HER2 Antibody Products, Services and Solutions
5.2.4 Novartis AG HER2 Antibody Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis AG Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer HER2 Antibody Products, Services and Solutions
5.3.4 Pfizer HER2 Antibody Revenue (US$ Million) & (2018-2023)
5.3.5 Abnova Corporation Recent Developments
5.4 Abnova Corporation
5.4.1 Abnova Corporation Profile
5.4.2 Abnova Corporation Main Business
5.4.3 Abnova Corporation HER2 Antibody Products, Services and Solutions
5.4.4 Abnova Corporation HER2 Antibody Revenue (US$ Million) & (2018-2023)
5.4.5 Abnova Corporation Recent Developments
5.5 InvivoGen
5.5.1 InvivoGen Profile
5.5.2 InvivoGen Main Business
5.5.3 InvivoGen HER2 Antibody Products, Services and Solutions
5.5.4 InvivoGen HER2 Antibody Revenue (US$ Million) & (2018-2023)
5.5.5 InvivoGen Recent Developments
5.6 Celltrion
5.6.1 Celltrion Profile
5.6.2 Celltrion Main Business
5.6.3 Celltrion HER2 Antibody Products, Services and Solutions
5.6.4 Celltrion HER2 Antibody Revenue (US$ Million) & (2018-2023)
5.6.5 Celltrion Recent Developments
5.7 Biocon Limited
5.7.1 Biocon Limited Profile
5.7.2 Biocon Limited Main Business
5.7.3 Biocon Limited HER2 Antibody Products, Services and Solutions
5.7.4 Biocon Limited HER2 Antibody Revenue (US$ Million) & (2018-2023)
5.7.5 Biocon Limited Recent Developments
5.8 Bio-Techne
5.8.1 Bio-Techne Profile
5.8.2 Bio-Techne Main Business
5.8.3 Bio-Techne HER2 Antibody Products, Services and Solutions
5.8.4 Bio-Techne HER2 Antibody Revenue (US$ Million) & (2018-2023)
5.8.5 Bio-Techne Recent Developments
6 North America
6.1 North America HER2 Antibody Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe HER2 Antibody Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific HER2 Antibody Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America HER2 Antibody Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa HER2 Antibody Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 HER2 Antibody Market Dynamics
11.1 HER2 Antibody Industry Trends
11.2 HER2 Antibody Market Drivers
11.3 HER2 Antibody Market Challenges
11.4 HER2 Antibody Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
